355 related articles for article (PubMed ID: 38239049)
21. Gut microbiota and allogeneic transplantation.
Wang W; Xu S; Ren Z; Jiang J; Zheng S
J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
[TBL] [Abstract][Full Text] [Related]
22. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.
Noor F; Kaysen A; Wilmes P; Schneider JG
J Innate Immun; 2019; 11(5):405-415. PubMed ID: 30286447
[TBL] [Abstract][Full Text] [Related]
23. Microbial metabolites and graft versus host disease.
Riwes M; Reddy P
Am J Transplant; 2018 Jan; 18(1):23-29. PubMed ID: 28742948
[TBL] [Abstract][Full Text] [Related]
24. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
25. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
Gray AN; DeFilipp Z
Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290
[TBL] [Abstract][Full Text] [Related]
26. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
27. From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease.
Limpert R; Pan P; Wang LS; Chen X
Front Immunol; 2023; 14():1192084. PubMed ID: 37359550
[TBL] [Abstract][Full Text] [Related]
28. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.
Ara T; Hashimoto D
Front Immunol; 2021; 12():713631. PubMed ID: 34512636
[TBL] [Abstract][Full Text] [Related]
29. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation.
Ciernikova S; Kasperova B; Drgona L; Smolkova B; Stevurkova V; Mego M
Blood Rev; 2021 Jul; 48():100790. PubMed ID: 33573867
[TBL] [Abstract][Full Text] [Related]
30. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
Köhler N; Zeiser R
Front Immunol; 2018; 9():3179. PubMed ID: 30705680
[TBL] [Abstract][Full Text] [Related]
31. Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Faraci M; Bonaretti C; Dell'Orso G; Pierri F; Giardino S; Angiero F; Blasi S; Farronato G; Di Marco E; Trevisiol A; Olcese E; Rufino L; Squillario M; Biassoni R
Sci Rep; 2024 Mar; 14(1):6708. PubMed ID: 38509104
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.
Simms-Waldrip TR; Sunkersett G; Coughlin LA; Savani MR; Arana C; Kim J; Kim M; Zhan X; Greenberg DE; Xie Y; Davies SM; Koh AY
Biol Blood Marrow Transplant; 2017 May; 23(5):820-829. PubMed ID: 28192251
[TBL] [Abstract][Full Text] [Related]
33. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
[TBL] [Abstract][Full Text] [Related]
34. Microbiome-intestine cross talk during acute graft-versus-host disease.
Rafei H; Jenq RR
Blood; 2020 Jul; 136(4):401-409. PubMed ID: 32526029
[TBL] [Abstract][Full Text] [Related]
35. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites.
Michonneau D; Latis E; Curis E; Dubouchet L; Ramamoorthy S; Ingram B; de Latour RP; Robin M; de Fontbrune FS; Chevret S; Rogge L; Socié G
Nat Commun; 2019 Dec; 10(1):5695. PubMed ID: 31836702
[TBL] [Abstract][Full Text] [Related]
36. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
[TBL] [Abstract][Full Text] [Related]
37. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Henig I; Yehudai-Ofir D; Zuckerman T
Haematologica; 2021 Apr; 106(4):933-946. PubMed ID: 33241674
[TBL] [Abstract][Full Text] [Related]
38. Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation.
Pianko MJ; Golob JL
Cancer Metastasis Rev; 2022 Jun; 41(2):367-382. PubMed ID: 35488106
[TBL] [Abstract][Full Text] [Related]
39. Intestinal microbiota-related effects on graft-versus-host disease.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
[TBL] [Abstract][Full Text] [Related]
40. Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
